Who is sponsoring NCT05905757?

NCT05905757 is sponsored by Yuzuncu Yil University.

What drugs are being tested in NCT05905757?

Interventions in NCT05905757: Dexmedetomidin + bupivacaine, Tramadol + Bupivacaine.

What condition does NCT05905757 study?

NCT05905757 studies Transversus Abdominis Plane Block.

Is NCT05905757 still recruiting?

NCT05905757 is currently completed. Last updated 15 June 2023.

Last reviewed 2023-06-15 · How we verify

NCT05905757

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adjuvant Dexmedetomidine and Tramadol in Subcostal Transversus Abdominis Plan Block

Completed NA Last updated 15 June 2023

What this trial tests

NA trial testing Dexmedetomidin + bupivacaine in Transversus Abdominis Plane Block in 60 participants. Completed in 3 April 2023.

Timeline

1 March 2022

Primary endpoint
1 March 2023

3 April 2023

Quick facts

Lead sponsor	Yuzuncu Yil University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	screening
Enrollment	60
Start date	1 March 2022
Primary completion	1 March 2023
Estimated completion	3 April 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Dexmedetomidin + bupivacaine
Tramadol + Bupivacaine — full drug profile →

Conditions studied

Transversus Abdominis Plane Block — all drugs for Transversus Abdominis Plane Block →

Sponsor

Yuzuncu Yil University

Who can join

Adults 20 to 60, any sex, with Transversus Abdominis Plane Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, dexmedetomidine and tramadol were added as adjuvant to bupivacaine in transversus abdominis plane block (TAP), intraoperative hemodynamics, opioid consumption, muscle relaxant use, postoperative analgesic effects and side effects (such as nausea-vomiting) were evaluated.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Intraoperative and Postoperative Effects of Dexmedetomidine and Tramadol Added as an Adjuvant to Bupivacaine in Transversus Abdominis Plane Block.
Korkutata Z, Tekeli AE, Kurt N. · · 2023 · cited 4× · PMID 38002616 · DOI 10.3390/jcm12227001
Intraoperative and Postoperative Effects of Dexmedetomidine and Tramadol Added as an Adjuvant to Bupivacaine in Transversus Abdominis Plane Block
Korkutata Z, Tekeli A, Kurt N. · · 2023

Verify or expand the search:

Other recruiting trials for Transversus Abdominis Plane Block

Currently open trials in the same condition.

NCT07458282 — The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain A · NA · recruiting
NCT07458295 — The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain A · NA · recruiting
NCT07273136 — Combined Subcostal and Lateral Transversus Abdominis Plane Block for Postoperative Analgesia Versus Thoracic Epidural An · NA · recruiting

Other Yuzuncu Yil University trials

Trials by the same sponsor.

NCT07525297 — Mulligan's Mobilization in Rotator Cuff Pathology · NA · not yet recruiting
NCT07523399 — Joint Health, Balance and Quality of Life in Adults With Hemophilia A · recruiting
NCT07416877 — The Effects of Dual-Task Exercises on Parameters After Total Knee Arthroplasty · NA · not yet recruiting
NCT07243925 — Effect of Family Involvement Intervention on Anxiety, Independence, and Psychological Resilience in CABG Surgery Patient · NA · active not recruiting
NCT07339410 — Physiotherapy to Improve Balance and Walking Capacity in Hemophilia · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05905757 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yuzuncu Yil University
Last refreshed: 15 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05905757.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing